Chimeric CD46/DAF molecules reveal a cryptic functional role for SCR1 of DAF in regulating complement activation

Molecular Immunology

Volumn 37, Issue 12-13, 2000, Pages 687-696

  Christiansen, Dale ^a   Loveland, Bruce ^b   Kyriakou, Peter ^b   Lanteri, Marc ^b   Rubinstein, Eric ^c   Gerlier, Denis ^a  

^a UNIVERSITÉ DE LYON   (France)

^b AUSTIN RESEARCH INSTITUTE   (Australia)

^c HÔPITAL PAUL BROUSSE   (France)

Author keywords

C3b deposition; CD46; CD55; Membrane cofactor protein

Indexed keywords

COMPLEMENT COMPONENT C3B; DECAY ACCELERATING FACTOR; MEMBRANE COFACTOR PROTEIN;

ARTICLE; CHIMERA; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; CONTROLLED STUDY; HUMAN; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SERUM;

EID: 0035077947     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(01)00002-5     Document Type: Article

References (49)

1. Binding of human complement component C4b-binding protein (C4bp) to Strectococcus pyogenes involves the C4b-binding site
2. Contribution of the repeating domains of membrane cofactor protein (CD46) of the complement system to ligand binding and cofactor activity
3. Solution structure of a pair of complement modules by nuclear magnetic resonance
4. Decay-accelerating factor (CD55), a glycosyphosphatidyl-inisitol-anchored complement regulatory protein, is a receptor for several echoviruses
5. A cluster of positively charged amino acids in the C4BP alpha-chain is crucial for C4b binding and factor I cofactor function
6. Localisation of classical and alternative pathway regulatory activity within the decay-accelerating factor
7. Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack
8. Crystal structure of two CD46 domains reveals an extended measles virus-binding surface
9. Protection against hyperacute xenograft rejection of transgenic rat hearts expressing human decay accelerating factor (DAF) transplanted into primates
10. Interaction of CD46 with measles virus: Accessory role of CD46 short consensus repeat IV
11. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor
12. Control of C3b and CSb deposition by CD46 (membrane cofactor protein) after alternative but not classical complement activation
13. Immune evasion of tumour cells using membrane-bound complement regulatory proteins
14. The C3-activator system: An alternative pathway of complement activation
15. The regulators of complement activation (RCA) gene cluster
16. Analysis of the short consensus repeats of human complement factor B by site-directed mutagenesis
17. Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding
18. Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46
19. Identification and quantification of complement regulator CD46 on normal human tissues
20. Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinurea
21. Membrane cofactor protein (CD46) protects cells predominantly from alternative complement pathway-mediated C3-fragment deposition and cytolysis
22. Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating CS convertases
23. Mapping of the domains required for decay acceleration activity of the human factor H-like protein 1 and factor H
24. Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1
25. Molecular modeling and mechanism of action of decay accelerating factor
26. Human complement regulators: A major target for pathogenic microorganisms
27. Membrane cofactor protein: Importance of N- and O-glycosylation for complement regulatory function
28. Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP, CD46)
29. CD46 (membrane cofactor protein) associates with multiple β integrins and tetraspanins
30. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes
31. Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids
32. A monomeric human C4b-462 binding protein (C4bp) more efficiently inactivates C3b than natural C4bp: Participation of C463 terminal domains in factor I-cofactor activity
33. Structure-activity relationship within the N-terminal short consensus repeats (SCR) of human CR1 (C3b/C4b receptor, CD35): SCR 3 plays a critical role in inhibition of the classical and alternative pathways of complement activation
34. A 3-D model for the measles virus receptor CD46 based on homology modeling, Monte Carlo simulations, and hemagglutinin binding studies
35. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus
36. A monoclonal antibody recognizes a human cell surface glycoprotein involved in measles virus binding
37. Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism
38. Pigs express multiple forms of decay-accelerating factor (CDS5), all of which contain only three short consensus repeats
39. A physical map of the human regulator of complement activation gene cluster linking the complement genes CR1, CR2, DAF, and C4BP
40. CD46 is a cellular receptor for human herpesvirus 6
41. Human regulator of complement activation (RCA) gene family proteins and their relationship to microbial infection
42. Distribution of membrane cofactor protein of complement on human peripheral blood cells. An altered form is found on granulocytes
43. Quantitative analysis of membrane cofactor protein (MCP) of complement: High expression of MCP on human leukemia cell lines, which is downregulated during cell differentiation
44. A human cell surface glycoprotein that carries Cromer-related blood group antigens on erythrocytes and is also expressed on leucocytes and platelets
45. Substitution of two amino acids confers C3b binding to the C4b binding site of CR1 (CD35). Analysis based on ligand binding by chimpanzee erythrocyte complement receptor
46. Transgenic expression of a CD46 (membrane cofactor protein) minigene: Studies of xenotransplantation and measles virus infection
47. Mode of entry of morbilliviruses
48. A critical role for murine complement regulator Crry in fetomaternal tolerance
49. Contribution of the complement control protein modules of C2 in C4b binding assessed by analysis of C2/Factor B chimeras